Diabetes is a complex metabolic disease presently affecting millions of people worldwide with serious acute and long-term complications. Metabolic disease or syndrome (MetS) is a multifactorial condition that presents a significant challenge to public health and biomedical research. Risk factors include both genetics and the environment. For a complex disease like MetS, multiple models when used together in a complementary fashion can enable research and progress in understanding disease etiology and pathogenesis towards a cure.
Absorption Systems has worked extensively on preclinical experimental models to provide investigators with different strategies. These animal models provide the essential tools to test novel therapies, new chemical entities and medical devices for the treatment of this disease.
As a Preclinical CRO, we specialize in evaluation:
- Continuous Glucose Monitoring
- HFD/STZ-induced T2D
- Choline and L-amino acid-deficient NAFLD/NASH
- Wound healing- acute and chronic
- Diabetic retinopathy